A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- OBSERVATIONAL
- Evidence population
- Human clinical study registration
- Participants
- 131
- Population
- ALL · 65 Years
- Duration
- 2021-09-08 to 2029-09-08
- Intervention
- Comparator
- Not reported
- Outcomes measured
- Overall response rate (at least PR) on induction therapy — From the date of inclusion to the end of induction therapy,…; Rate of treatment discontinued(TD) — The time from the date of inclusion to the date of treatment discontinued from any…; Treatment related adverse event(TRAE) — Baseline, end of every induction cycle and maintenance cycle, until disease pro…; Early mortality(EM) — The time from the date of inclusion to the date of death from any cause, up to 24 months.; Progression-free survival(PFS) — The time from the date of inclusion to the date of first documented evidence of diseas…; Overall survival (OS) — The time from the date of inclusion to the date of death from any cause, up to 24 months
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Source terminology contains: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.